Open menu
Paytm Money logo
search-placeholder
search
Mutual Fund Details
search-placeholder
search
Tata Mutual Fund

Tata India Pharma & HealthCare Fund Direct-Growth

NAV
returns change indicator
9.3531
as on 16 Oct 2019, 09:50 PM
0.0541(0.58%)
Last Change
loaderloader

Schemes Managed By

Start SIP in this Mutual Fund

Min SIP Amount
500
Suggested Date
19th of Every Month
Invest via SIP

Investment Performance

would have given a return of
110,871
star
121,647
star
92,371
star
96,679
star
Bank Account
Fixed Deposit
Regular Mutual Fund
This Fund on Paytm Money
This Mutual Fund
3,321
Profit (absolute return)
3.32%
in the last
1m
3m
1y
3y
max
+1% Higher Returns
With Direct Plans on Paytm Money

Investment Returns

In the last 3 months
0.81%
In the last 6 months
4.27%
In the last 1 year
1.79%
In the last 3 years
3.32%
In the last 5 years
NA
In the last 10 years
NA
Absolute Returns
CAGR

Scheme Riskometer

low
low
moderately low
moderately low
moderate
moderate
moderately high
moderately high
high
high
indicator
Investors understand that their principal will be at high risk

Scheme Information

Tata India Pharma & HealthCare Fund Direct-Growth
Tata India Pharma & HealthCare Fund Direct-Growth
as of 16 Oct 2019, 09:50 PM
167.93 Cr
Scheme Asset Size
Fund Type
Open-End
Exit Load
Exit load of 0.25% if redeemed within 3 months
1.16%
Expense Ratio
Plan
Growth
4.21%
Cash Holding
Benchmark
NIFTY Pharma Total Return Index
Scheme Document
Benchmark
NIFTY Pharma Total Return Index
Exit Load
Exit load of 0.25% if redeemed within 3 months
Scheme Document

Sectors Holding in this Mutual Fund

as on 31 Aug 2019
Sort By
Healthcare
96.22%
161.59 Cr
Cash Holding
3.78%
6.35 Cr

Companies Holding in this Mutual Fund

as on 31 Aug 2019
Sort By
Dr. Reddy's Laboratories Ltd.
11.89%
19.97 Cr
Sun Pharmaceutical Inds. Ltd.
10.72%
18.00 Cr
Divi's Laboratories Ltd.
9.87%
16.57 Cr
Lupin Ltd.
8.88%
14.91 Cr
Abbott India Ltd.
8.14%
13.67 Cr
Ipca Laboratories Ltd.
7.58%
12.73 Cr
Procter & Gamble Health Ltd.
7.21%
12.11 Cr
Aurobindo Pharma Ltd.
5.74%
9.64 Cr
Apollo Hospitals Enterprise Ltd.
5.11%
8.58 Cr
Alembic Pharmaceuticals Ltd.
4.36%
7.32 Cr
View All
View All

About Tata India Pharma & HealthCare Fund Direct-Growth

Tata India Pharma & HealthCare Fund Direct-Growth is a Equity mutual fund scheme from Tata Mutual Fund. This scheme was launched on 28 Dec 2015 and is currently managed by its fund manager Sailesh Jain. It has an AUM of ₹167.93 Crores and the latest NAV decalared is ₹9.353 as on 16 Oct 2019 at 9:50 pm.
Tata India Pharma & HealthCare Fund Direct-Growth scheme return performance in last 1 year is -1.79%, in last 3 years is -3.32% and -6.80% since scheme launch. The min. SIP amount to invest in this scheme is ₹500.

Scheme Details

AUM:167.93 Cr
Category:Equity: Sectoral-Pharma
Launch Date:28 Dec 2015
Fund Type:Open-End

Scheme Objective

The scheme seeks long term capital appreciation by investing atleast 80% of it's net assets in equity/equity related instruments of the companies in the pharma & healthcare sectors in India.

AMC Information

Tata Mutual Fund
Tata Mutual Fund
View AMC Details
43,111.47 Cr
AUM
94
Schemes
Address
Address
9th Floor, Mafatlal Centre,Nariman Point,400021
Phone Number
Phone Number
Phone : 1800-209-0101